In accordance with the results of mass spectrometric profiling of tumor tissue proteomes obtained from the control and treated groups of animals, the results of Western blot analysis have also revealed decreased levels of Rps3 in all treated groups in comparison with the control group (Figure 5). This evidence concerns the gene RPS3 and neoplasm.